Additionally, gasdermin D activation also results in smooth muscle cell (SMC) phenotype switching, namely from contractible towards secretory SMCs that contribute to AAA pathogenesis by producing proinflammatory mediators in a pore-independent ways. The gene discussed is GSDMD; the disease is triple-A syndrome.